Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

New Strategies to Detect Cancers in Carriers of Mutations in RB1 (NIRBTEST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04164134
Recruitment Status : Recruiting
First Posted : November 15, 2019
Last Update Posted : April 2, 2021
Sponsor:
Collaborators:
University Hospital, Essen
Institut Curie
Ligue contre le cancer, France
Information provided by (Responsible Party):
Armida W. M. Fabius, VU University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 31, 2022
Estimated Study Completion Date : May 31, 2022